Drugs / Bmab3000
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07299955 Comparator | Feb → Jun 2026 overdue | — | Biocon Biologics UK Ltd | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bmab3000 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07299955 ↗ |
| Route | Subcutaneous | “single subcutaneous injection” NCT07299955 ↗ |